NM-Carbomer 971P Carbomer Homopolymer Type A
NM-Carbomer 971P Carbomer Homopolymer Type A

NM-Carbomer 971P Carbomer Homopolymer Type A

FOB
Spedizione:
空运, 陆运, 海运
Campione:Supporto gratuitoOttieni campioni
Dettagli del prodotto
Domande frequenti
Dettagli essenziali
Spedizione:空运, 陆运, 海运
numero di specificazione:NMC-71G
Introduzione del prodotto
NM-Carbomer 71G
NM-Carbomer71G meets the current edition of the following monographs:
 United States Pharmacopeia/National Formulary (USP/NF) monograph for Carbomer Homopolymer Type A 
European Pharmacopeia (Ph. Eur.) monograph for Carbomers
China Pharmacopeia (ChP) monograph for Carbomer Homopolymer Type A
General Product Characteristics
Appearance:  White granules
 Odor: Slightly acetic 
Model No. :NM-Carbomer 71G
Port Of Dispatch :Shanghai, Guangzhou or other ports in china
Original Region :china
Lead Time :in 7 days

Details
NM-Carbomer 71G
NM-Carbomer71G meets the current edition of the following monographs:
United States Pharmacopeia/National Formulary (USP/NF) monograph for Carbomer Homopolymer Type A 
European Pharmacopeia (Ph. Eur.) monograph for Carbomers
China Pharmacopeia (ChP) monograph for Carbomer Homopolymer Type A

General Product Characteristics
Appearance:  White granules
Odor: Slightly acetic 

Features and Benefits 
The unique feature of NM-Carbomer 71G NF is its free-flowing granular form, allowing for tablet manufacturing by direct compression. Direct compression plays a key role in the pharmaceutical industry as it is the most economical as well as the shortest and most direct way to produce an oral tablet. However, in order to achieve a robust final dosage form, a direct compression formulation requires an excipient like Carbopol 71G NF that exhibits good flowability and compressibility
 l Extended-release agent
 l Direct compressible
 l Bio adhesion agent
 l Tablet binder

Recommended Applications
 l Semisolids & gels
 l Extended-release oral solid doses
 l Oral drug delivery
 l Oral care

Usage Levels:
 l Oral solid dose – extended release: 5-10 wt.%
 l Oral solid dose – immediate release: 0.5-3 wt.%
 l Oral solutions & suspensions: 0.2-1 wt.%
 l Typical recommended dosage at 0.2~1.0 wt. %

Lascia le tue informazioni e
ti contatteremo.

Prodotti

Cura personale

Assistenza sanitaria

Cura della casa e altri settori industriali

Contatto rapido

Tel: +86 191 5921 4488

E-mail: sale01@chinanewman.cn

Base produttiva: North No.7 Road, Modern Industrial Park, Contea di Jinzhai, Lu'an, Anhui 237300, Cina

Tel
WhatsApp